Results 71 to 80 of about 133,753 (204)

Changes in HIV post-exposure prophylaxis prescriptions before and after the introduction of HIV pre-exposure prophylaxis at a sexual health clinic in Melbourne, Australia, 2011–2021

Australian and New Zealand Journal of Public Health
Objective: HIV pre-exposure prophylaxis (PrEP) became available in Victoria, Australia, in 2016. We examined non-occupational post-exposure prophylaxis (nPEP) usage among gay, bisexual and other men who have sex with men (MSM) before and after PrEP ...
Ranjit S. Samra, Christopher K. Fairley, Jason J. Ong, Ei T. Aung, Eric PF. Chow   +4 more
doaj   +1 more source

Evidence-Based Study of Medication Compliance Project in Hiv Prevention Using Pre-Exposure Prophylaxis (Prep) Antivirals for HIV-Negative Males [PDF]

, 2018
In 2012, emtricitabine/tenofovir was the only Food and Drug Administration-approved medication for pre-exposure prophylaxis (PrEP) used in human immunodeficiency virus (HIV) prevention.
Ho, Ming-Chun
core   +1 more source

Estimated Risk of HIV Acquisition and Practice for Preventing Occupational Exposure: A Study of Healthcare Workers at Tumbi and Dodoma Hospitals, Tanzania. [PDF]

, 2013
Health care workers (HCWs) are at risk of acquiring human immuno-deficiency virus (HIV) and other infections via exposure to infectious patients' blood and body fluids.
A Kilale, A Pruss-Ustun, AA Reda, B Doebbeling, B Gumodoka, C Denise, CS Kessler, de lTX, DM Cardo, E Mossdorf, Emmanuel Makundi, G Morino, Godfrey M Mubyazi, Hamisi M Malebo, Health Protection Agency Centre for Infections. Eye of the needle, Hussein Mohamed, ILO, WHO: Joint Guidelines on Health Services and HIV/AIDS, JA Rabbitts, Kijakazi O Mashoto, M Zhang, MG Worthington, OSHA, S Sohn, S Tuma, WHO: International Council of Nurses (ICN), WHO: Occupational Health   +25 more
core   +1 more source

Remediated sexuality: the meanings of postand pre-exposure prophylaxis for HIV [PDF]

Saúde e Sociedade
This article discusses the sexual character of HIV preand post-exposure prophylaxis (PEP and PrEP, respectively). It derives from a socio-anthropological study on the biomedicalization of responses to HIV that analyzed the offer of these prophylaxes in ...
Mauro Brigeiro, Simone Monteiro
doaj   +1 more source

Self-Reported Occupational Exposure to HIV and Factors Influencing its Management Practice: A Study of Healthcare Workers in Tumbi and Dodoma Hospitals, Tanzania. [PDF]

, 2013
Blood borne infectious agents such as hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune deficiency virus (HIV) constitute a major occupational hazard for healthcare workers (HCWs).
A Karstaedt, A Sharma, B Doebbeling, B Gumodoka, B Shariati, C Denise, C Lin, C Sagoe-Moses, CM Mangione, D Strader, F Pont, FM Nsubuga, G Bennet, G Frijstein, Godfrey M Mubyazi, Government of India, Hamisi M Malebo, Hussein Mohamed, JL Gerberding, K Twitchell, Kijakazi O Mashoto, M Zhang, MM Chagani, MMWR, RC Merchant, SK Lwanga, SV Manyele, WHO, Y Hutin   +28 more
core   +1 more source

Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework. [PDF]

, 2017
Placebo-controlled trials of pre-exposure prophylaxis (PrEP) have reported challenges with study-product uptake and use, with the greatest challenges reported in studies with young women in sub-Saharan Africa.
Amico, K Rivet, Atujuna, Millicent, Bekker, Linda-Gail, Dye, Bonnie J, Elharrar, Vanessa, Grant, Robert M, Roux, Surita, Sebastian, Elaine, Wallace, Melissa   +8 more
core   +2 more sources

Low clinical impact of HIV drug resistance mutations in oral pre-exposure prophylaxis: a systematic review and meta-analysis

AIDS Research and Therapy
Introduction Despite the widespread use of pre-exposure prophylaxis (PrEP) in preventing human immunodeficiency virus (HIV) transmission, scant information on HIV drug resistance mutations (DRMs) has been gathered over the past decade.
Brian Eka Rachman, Siti Qamariyah Khairunisa, Citrawati Dyah Kencono Wungu, Tri Pudy Asmarawati, Musofa Rusli, Bramantono, M. Vitanata Arfijanto, Usman Hadi, Masanori Kameoka, Nasronudin   +9 more
doaj   +1 more source

Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy [PDF]

, 2016
Post-exposure prophylaxis (PEP) for leprosy is administered as one single dose of rifampicin (SDR) to the contacts of newly diagnosed leprosy patients. SDR reduces the risk of developing leprosy among contacts by around 60 % in the first 2-3 years after ...
Anthony, Richard, Bratschi, Martin W., Cambau, Emmanuelle, Cavaliero, Arielle, Kasang, Christa, Mieras, Liesbeth, Perera, Geethal, Reichman, Lee, Richardus, Jan Hendrik, Saunderson, Paul, Steinmann, Peter, van Brakel, Wim, van den Broek, Jacques, Yew, Wing Wai   +13 more
core   +6 more sources

Pre-exposure prophylaxis (PrEP) means more exposure?

DST, 2018
During the last Conference for the Prevention of Sexually Transmitted Diseases of the Centers for Disease Control and Prevention (CDC-USA), in 2018, the advent of a new era in the fight against HIV infection was very clear(1).
Andrea Menezes Gonçalves
doaj  

Purified Vero Cell Rabies Vaccine (PVRV, Verorab^®): A Systematic Review of Intradermal Use Between 1985 and 2019

Tropical Medicine and Infectious Disease, 2020
The purified Vero cell rabies vaccine (PVRV; Verorab®, Sanofi Pasteur) has been used in rabies prevention since 1985. Evolving rabies vaccination trends, including shorter intradermal (ID) regimens with reduced volume, along with WHO recommendation ...
Thomas Moulenat, Céline Petit, Valérie Bosch Castells, Guy Houillon   +3 more
doaj   +1 more source